Meet us next:   The Cell & Gene Meeting on the Mesa 2025 – 6-8 October (in person) & 9-10 October (virtual)  ●  ESGCT Congress 2025 – 7-10 October  ●  ELRIG – Drug Discovery – 21-22 October  ●  BIO-EUROPE 2025 –  ●  more on our events calendar

Breast Cancer (Triple Negative) Related Human Specimens

58 Breast Cancer (Triple Negative) Patients

Note: The majority of patients have donated multiple samples.

Biorepository icon: frozen samples

Frozen samples: 48

Biorepository icon: FFPE samples

FFPE: 53

Biorepository icon: DNA samples

DNA: 2

Additional Information

  • Comprehensive, de-identified, covariate data such as age, gender, diet, body mass index (BMI), and race in addition to complete diagnostic and treatment history
  • Access to additional samples and longitudinal data are available for some custom programs.

Speak to our experts

Global Biorepository

Inventory by disease

NEW COVID-19

On the REPROCELL blog

Latest in Drug Discovery

How Human Tissue Testing Adds Commercial Value for Shareholders

How Human Tissue Testing Adds Commercial Value for Shareholders

Discover how human tissue testing enhances shareholder value, exploring its impact on drug discovery, precision medicine, and regenerative medicine within the life sciences industry.

03 September 2025

NIH Announces End to Exclusive Funding for Animal Model Research

NIH Announces End to Exclusive Funding for Animal Model Research

NIH ends exclusive funding for animal model research, promoting New Approach Methodologies like organ-on-a-chip systems and human tissue testing.

18 August 2025

Subcutaneous Artery Assays Help Us to Understand Blood Pressure Regulation

Subcutaneous Artery Assays Help Us to Understand Blood Pressure Regulation

Explore how subcutaneous artery assays enhance understanding of blood pressure regulation and aid in the development of safer, more effective cardiovascular drugs.

07 July 2025

More in Drug Discovery